Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis
- PMID: 18204260
- DOI: 10.1159/000111486
Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitis
Abstract
Recent progress in both basic and clinical research has led us to develop sophisticated and effective medical therapy of ulcerative colitis (UC). Although classical agents such as aminosalicylates, corticosteroids and immunomodulatory drugs have remained as the gold standard for decades, their novel formulations and/or dosage regimens have changed their placements in the medical management of UC. In addition, studies have shown that a number of novel therapeutic agents, designed to target specific mechanisms involved in the inflammatory cascade, have efficacy for the treatment of UC and they will have significant clinical impacts in the near future. A clear understanding of the proven and potential benefits of both the standard and emerging therapies will be required for the optimum individual care of patients with varied clinical presentations.
2008 S. Karger AG, Basel
Similar articles
-
Efficacy and safety of drugs for ulcerative colitis.Expert Opin Drug Saf. 2010 Jul;9(4):573-92. doi: 10.1517/14740331003639412. Expert Opin Drug Saf. 2010. PMID: 20377475 Review.
-
Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis.Aliment Pharmacol Ther. 2008 Oct 1;28(7):815-29. doi: 10.1111/j.1365-2036.2008.03800.x. Aliment Pharmacol Ther. 2008. PMID: 18627362 Review.
-
Update on the management of ulcerative colitis.Acta Med Iran. 2012;50(6):363-72. Acta Med Iran. 2012. PMID: 22837114 Review.
-
Clinical practice in the management of ulcerative colitis--an Italian survey.Dig Liver Dis. 2008 Jul;40 Suppl 2:S214-9. doi: 10.1016/S1590-8658(08)60528-9. Dig Liver Dis. 2008. PMID: 18598991
-
A review of infliximab use in ulcerative colitis.Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Clin Ther. 2008. PMID: 18343261 Review.
Cited by
-
Thermosensitive and pH-responsive quercus infectoria gall-containing gel with long-lasting anti-inflammatory activity for ulcerative colitis.Heliyon. 2024 Aug 13;10(19):e36225. doi: 10.1016/j.heliyon.2024.e36225. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39435110 Free PMC article.
-
Pectic polysaccharides ameliorate the pathology of ulcerative colitis in mice by reducing pyroptosis.Ann Transl Med. 2022 Mar;10(6):347. doi: 10.21037/atm-22-877. Ann Transl Med. 2022. PMID: 35434032 Free PMC article.
-
β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis.Front Pharmacol. 2023 Oct 26;14:1218477. doi: 10.3389/fphar.2023.1218477. eCollection 2023. Front Pharmacol. 2023. PMID: 37954856 Free PMC article.
-
Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: A systematic review and meta-analysis.Medicine (Baltimore). 2017 Dec;96(49):e8659. doi: 10.1097/MD.0000000000008659. Medicine (Baltimore). 2017. PMID: 29245225 Free PMC article. Review.
-
Association between serum vitamin D, uric acid, C-reactive protein, and disease severity in ulcerative colitis: A retrospective study.Medicine (Baltimore). 2024 Oct 11;103(41):e40019. doi: 10.1097/MD.0000000000040019. Medicine (Baltimore). 2024. PMID: 39465814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
